Conditional Immortalization of Human Cardiac Fibroblasts for Pro-Fibrotic and Anti-Fibrotic Drug Screening
Background: The development of anti-fibrotic therapies for heart failure is hindered by the absence of phenotypically stable and scalable human cardiac fibroblast (CFB) models suitable for pre-clinical drug screening. This study aimed to establish and validate a conditionally immo...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
IMR Press
2026-04-01
|
| Collection: | Frontiers in Bioscience-Landmark |
| Sujets: | |
| Accès en ligne: | https://www.imrpress.com/journal/FBL/31/5/10.31083/FBL49465 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|